Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL513P is a member of the large family of 7SL RNA pseudogenes present in the human genome[3]. The 7SL RNA is the functional RNA component of the Signal Recognition Particle (SRP), which is essential for the targeting of secretory proteins to the endoplasmic reticulum during translation[1][5]. RN7SL513P and similar pseudogenes originate from reverse transcription and genomic integration events, resulting in truncated, non-functional copies dispersed throughout the genome[3]. While some pseudogenes are transcribed and may affect regulation of parental genes through RNA-mediated mechanisms, specific evidence for RN7SL513P's transcription, function, or disease involvement is lacking[4][6]. It is not considered a receptor, enzyme, transporter, nor a validated therapeutic target.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 513, pseudogene (RN7SL513P).